30545741|t|Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
30545741|a|OBJECTIVE: Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of diabetic patients leading to significant morbidity. There is impaired neurotrophic growth factor signaling, AMP-activated protein kinase (AMPK) activity and mitochondrial function in dorsal root ganglia (DRG) of animal models of type 1 and type 2 diabetes. We hypothesized that sub-optimal insulin-like growth factor 1 (IGF-1) signaling in diabetes drives loss of AMPK activity and mitochondrial function, both contributing to development of DSPN. METHODS: Age-matched control Sprague-Dawley rats and streptozotocin (STZ)-induced type 1 diabetic rats with/without IGF-1 therapy were used for in vivo studies. For in vitro studies, DRG neurons from control and STZ-diabetic rats were cultured and treated with/without IGF-1 in the presence or absence of inhibitors or siRNAs. RESULTS: Dysregulation of mRNAs for IGF-1, AMPKalpha2, ATP5a1 (subunit of ATPase), and PGC-1beta occurred in DRG of diabetic vs. control rats. IGF-1 up-regulated mRNA levels of these genes in cultured DRGs from control or diabetic rats. IGF-1 treatment of DRG cultures significantly (P < 0.05) increased phosphorylation of Akt, P70S6K, AMPK and acetyl-CoA carboxylase (ACC). Mitochondrial gene expression and oxygen consumption rate (spare respiratory capacity), ATP production, mtDNA/nDNA ratio and neurite outgrowth were augmented (P < 0.05). AMPK inhibitor, Compound C, or AMPKalpha1-specific siRNA suppressed IGF-1 elevation of mitochondrial function, mtDNA and neurite outgrowth. Diabetic rats treated with IGF-1 exhibited reversal of thermal hypoalgesia and, in a separate study, reversed the deficit in corneal nerve profiles. In diabetic rats, IGF-1 elevated the levels of AMPK and P70S6K phosphorylation, raised Complex IV-MTCO1 and Complex V-ATP5a protein expression, and restored the enzyme activities of Complex IV and I in the DRG. IGF-1 prevented TCA metabolite build-up in nerve. CONCLUSIONS: In DRG neuron cultures IGF-1 signals via AMPK to elevate mitochondrial function and drive axonal outgrowth. We propose that this signaling axis mediates IGF-1-dependent protection from distal dying-back of fibers in diabetic neuropathy.
30545741	0	28	Insulin-like growth factor-1	Gene	24482
30545741	39	43	AMPK	Gene	78975
30545741	132	147	type 1 diabetes	Disease	MESH:D003922
30545741	160	196	Diabetic sensorimotor polyneuropathy	Disease	MESH:D003929
30545741	198	202	DSPN	Disease	MESH:D003929
30545741	231	233	of	Gene	6688
30545741	234	242	diabetic	Disease	MESH:D003920
30545741	243	251	patients	Species	9606
30545741	342	370	AMP-activated protein kinase	Gene	78975
30545741	372	376	AMPK	Gene	78975
30545741	463	489	type 1 and type 2 diabetes	Disease	MESH:D003924
30545741	524	552	insulin-like growth factor 1	Gene	24482
30545741	554	559	IGF-1	Gene	24482
30545741	574	582	diabetes	Disease	MESH:D003920
30545741	598	602	AMPK	Gene	78975
30545741	673	675	of	Gene	6688
30545741	676	680	DSPN	Disease	MESH:D003929
30545741	726	730	rats	Species	10116
30545741	735	749	streptozotocin	Chemical	MESH:D013311
30545741	751	754	STZ	Chemical	MESH:D013311
30545741	764	779	type 1 diabetic	Disease	MESH:D003922
30545741	780	784	rats	Species	10116
30545741	798	803	IGF-1	Gene	24482
30545741	894	897	STZ	Chemical	MESH:D013311
30545741	898	906	diabetic	Disease	MESH:D003920
30545741	907	911	rats	Species	10116
30545741	951	956	IGF-1	Gene	24482
30545741	1045	1050	IGF-1	Gene	24482
30545741	1052	1062	AMPKalpha2	Gene	78975
30545741	1064	1070	ATP5a1	Gene	65262
30545741	1096	1105	PGC-1beta	Gene	291567
30545741	1125	1133	diabetic	Disease	MESH:D003920
30545741	1146	1150	rats	Species	10116
30545741	1152	1157	IGF-1	Gene	24482
30545741	1231	1239	diabetic	Disease	MESH:D003920
30545741	1240	1244	rats	Species	10116
30545741	1246	1251	IGF-1	Gene	24482
30545741	1332	1335	Akt	Gene	24185
30545741	1337	1343	P70S6K	Gene	83840
30545741	1345	1349	AMPK	Gene	78975
30545741	1418	1424	oxygen	Chemical	MESH:D010100
30545741	1472	1475	ATP	Chemical	MESH:D000255
30545741	1554	1558	AMPK	Gene	78975
30545741	1570	1580	Compound C	Chemical	-
30545741	1585	1595	AMPKalpha1	Gene	65248
30545741	1622	1627	IGF-1	Gene	24482
30545741	1694	1702	Diabetic	Disease	MESH:D003920
30545741	1703	1707	rats	Species	10116
30545741	1721	1726	IGF-1	Gene	24482
30545741	1749	1768	thermal hypoalgesia	Disease	MESH:D020886
30545741	1846	1854	diabetic	Disease	MESH:D003920
30545741	1855	1859	rats	Species	10116
30545741	1861	1866	IGF-1	Gene	24482
30545741	1890	1894	AMPK	Gene	78975
30545741	1899	1905	P70S6K	Gene	83840
30545741	1941	1946	MTCO1	Gene	26195
30545741	2054	2059	IGF-1	Gene	24482
30545741	2070	2073	TCA	Chemical	MESH:D014238
30545741	2140	2145	IGF-1	Gene	24482
30545741	2158	2162	AMPK	Gene	78975
30545741	2270	2275	IGF-1	Gene	24482
30545741	2333	2352	diabetic neuropathy	Disease	MESH:D003929
30545741	Association	MESH:D003929	78975
30545741	Association	MESH:D003920	78975
30545741	Association	MESH:D003929	24482
30545741	Positive_Correlation	24482	83840
30545741	Association	24482	65248
30545741	Association	MESH:D003922	24482
30545741	Positive_Correlation	24185	24482
30545741	Negative_Correlation	MESH:D020886	24482
30545741	Positive_Correlation	24482	78975
30545741	Association	MESH:D003920	291567
30545741	Association	MESH:D003920	65262
30545741	Positive_Correlation	MESH:D013311	MESH:D003922
30545741	Association	MESH:D003920	24482
30545741	Association	MESH:D003922	78975

